Despite insufficient data from prospective randomized trials of neoadjuvant systemic therapy (NST), NST has become widely accepted as the treatment of choice for patients with locally advanced disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback